O
OrbiMed’s Passage Bio PASG Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.42M | Sell |
6,055,300
-979,326
| -14% | -$392K | 0.06% | 83 |
|
2025
Q1 | $2.48M | Sell |
7,034,626
-370,243
| -5% | -$131K | 0.06% | 85 |
|
2024
Q4 | $4.2M | Sell |
7,404,869
-2,418,007
| -25% | -$1.37M | 0.09% | 87 |
|
2024
Q3 | $6.88M | Sell |
9,822,876
-301,700
| -3% | -$211K | 0.12% | 85 |
|
2024
Q2 | $8.04M | Hold |
10,124,576
| – | – | 0.16% | 79 |
|
2024
Q1 | $13.7M | Hold |
10,124,576
| – | – | 0.25% | 74 |
|
2023
Q4 | $10.2M | Hold |
10,124,576
| – | – | 0.2% | 75 |
|
2023
Q3 | $6.66M | Hold |
10,124,576
| – | – | 0.14% | 91 |
|
2023
Q2 | $9.53M | Buy |
10,124,576
+1,192,577
| +13% | +$1.12M | 0.17% | 87 |
|
2023
Q1 | $8.55M | Hold |
8,931,999
| – | – | 0.17% | 87 |
|
2022
Q4 | $12.3M | Hold |
8,931,999
| – | – | 0.24% | 73 |
|
2022
Q3 | $11.2K | Hold |
8,931,999
| – | – | 0.21% | 81 |
|
2022
Q2 | $21.1K | Buy |
8,931,999
+1,600,000
| +22% | +$3.78K | 0.38% | 60 |
|
2022
Q1 | $22.7M | Buy |
7,331,999
+369,100
| +5% | +$1.14M | 0.37% | 64 |
|
2021
Q4 | $44.2M | Hold |
6,962,899
| – | – | 0.57% | 51 |
|
2021
Q3 | $69.4M | Hold |
6,962,899
| – | – | 0.76% | 41 |
|
2021
Q2 | $92.2M | Hold |
6,962,899
| – | – | 0.93% | 34 |
|
2021
Q1 | $122M | Hold |
6,962,899
| – | – | 1.14% | 25 |
|
2020
Q4 | $178M | Hold |
6,962,899
| – | – | 1.56% | 16 |
|
2020
Q3 | $91.3M | Hold |
6,962,899
| – | – | 1.15% | 26 |
|
2020
Q2 | $190M | Hold |
6,962,899
| – | – | 2.68% | 9 |
|
2020
Q1 | $110M | Buy |
+6,962,899
| New | +$110M | 1.84% | 16 |
|